A nucleotide insertion in Exon 2 is responsible for a new HLA-DRB1 null allele, HLA-DRB1*14:166N

HLA : Immune Response Genetics
M TestiM Andreani

Abstract

DRB1*14 is identical to DRB1*14:54:01 except for a single nucleotide insertion of A in position 175 in Exon 2.

References

Feb 9, 2010·Tissue Antigens·Steven G E Marsh, UNKNOWN WHO Nomenclature Committee for Factors of the HLA System
Apr 2, 2010·Tissue Antigens·S G E MarshJ Trowsdale
Aug 24, 2010·Tissue Antigens·Steven G E Marsh, UNKNOWN WHO Nomenclature Committee for Factors of the HLA System

❮ Previous
Next ❯

Citations

Feb 2, 2016·Human Immunology·Steven G E Marsh, UNKNOWN WHO Nomenclature Committee for Factors of the HLA System
Feb 20, 2016·HLA : Immune Response Genetics·Steven G E Marsh, UNKNOWN WHO Nomenclature Committee for Factors of HLA System

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.